Statistics

Total Visits

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment30

Select a period of time:

Number of views in the range

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment20

Views

Views
May 20243
June 20240
July 20241
August 20247
September 20246
October 20243
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
 

Top cities views

Views
Chicago5
Fort Worth2
Prineville1